Unknown

Dataset Information

Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures.


ABSTRACT:

Background

Dupilumab was equally effective among all racial subgroups in clinical trials, but a direct comparison in daily practice is lacking.

Objectives

To investigate the effectiveness of dupilumab in patients with atopic dermatitis (AD) in the Netherlands and Japan over 80 weeks of treatment.

Methods

A longitudinal comparative cohort study was conducted in patients with AD who were treated with dupilumab in daily practice. We used linear mixed-effects models to determine changes over time.

Results

We found statistically significant differences in sex, disease onset, body mass index and therapeutic history between Dutch (n = 208) and Japanese (n = 153) patients. The baseline Eczema Area and Severity Index (EASI) score was higher in Japanese patients (23·8 vs

SUBMITTER: de Wijs LEM 

PROVIDER: S-EPMC8453550 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature